Financials
- Market Capitalization 1.82 B
- Employee 130
- Founded 2019
- CEO N/A
- Website www.septerna.com
- Headquarter Delaware, United States
- FIGI BBG014WY1V28
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-25.35
Rapporto prezzo/fatturato
26.85
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 2065 | VIR Vir Biotechnology, Inc. - Common Stock | 10.83 USD | -4.24% | +11.19% | +25.78% | +81.10% | 1.83 B USD | ||
| 2070 | INBX Inhibrx Biosciences, Inc. - Common Stock | 123.41 USD | -0.42% | +17.53% | +52.34% | +53.15% | 1.82 B USD | ||
| 2076 | NTLA Intellia Therapeutics, Inc. - Common Stock | 12.87 USD | -1.83% | +2.14% | +17.97% | -6.20% | 1.80 B USD | ||
| 2083 | FTRE Fortrea Holdings Inc. - Common Stock | 18.81 USD | -0.27% | +3.69% | -8.06% | +95.12% | 1.79 B USD |